Home/Filings/4/0001012975-20-000800
4//SEC Filing

CHENAULT KENNETH I 4

Accession 0001012975-20-000800

CIK 0001639225other

Filed

Nov 2, 7:00 PM ET

Accepted

Nov 3, 5:00 PM ET

Size

19.6 KB

Accession

0001012975-20-000800

Insider Transaction Report

Form 4
Period: 2020-10-30
Transactions
  • Disposition from Tender

    Common Stock

    2020-10-3013,943,2160 total(indirect: See footnote)
  • Other

    Common Stock

    2020-10-30+7,922982,160 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30653,9180 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-302,892,6810 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30982,1600 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2020-10-30+7,922982,160 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30982,1600 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-302,892,6810 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-3013,943,2160 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30653,9180 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2020-10-30+7,922982,160 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30653,9180 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30982,1600 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-302,892,6810 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-3013,943,2160 total(indirect: See footnote)
Transactions
  • Disposition from Tender

    Common Stock

    2020-10-30653,9180 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-3013,943,2160 total(indirect: See footnote)
  • Other

    Common Stock

    2020-10-30+7,922982,160 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-30982,1600 total(indirect: See footnote)
  • Disposition from Tender

    Common Stock

    2020-10-302,892,6810 total(indirect: See footnote)
Footnotes (6)
  • [F1]On October 30, 2020, shares of Common Stock of the Issuer held by 7wire Ventures Fund, L.P. were distributed to its underlying members. As part of such distribution, 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, received 7,922 shares of the Issuer's Common Stock.
  • [F2]Pursuant to an Agreement and Plan of Merger dated as of August 5, 2020, between Livongo Health, Inc., or Livongo, Teladoc Health, Inc., or Teladoc and Tempranillo Merger Sub, Inc., a wholly owned subsidiary of Teladoc, upon completion of the merger, each share of Livongo common stock was automatically converted into the right to receive 0.5920 of a share of Teladoc common stock and $4.24 in cash, without interest, together with cash in lieu of any fractional shares.
  • [F3]17,933 shares were held by 7wire, and the balance were held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. General Catalyst Group Management, LLC, or GCGM, is the manager of GP VIII LLC. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of GCGM. As the Managing Members of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, Kenneth Chenault, Joel Cutler, David Fialkow and Hemant Taneja, a director of the Issuer, shared voting and investment power with respect to shares held by 7wire and GC Group VIII LP.
  • [F4]The shares were held by GC Venture LH Manager, LLC. GCGMH is the manager of GCGM, which is the manager of GC Venture LH Manager, LLC. GCGM may also be a member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Venture LH Manager, LLC. GCGM Investment Holdings, L.P. is a non-managing member of GC Venture LH Manager, LLC with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.
  • [F5]The shares were held by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VIII Supplemental.
  • [F6]The shares were held by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., or GP VI LP, which is the general partner of GC Group VI LP. GCGMH is the manager GCGM, which is the manager of GP VI LLC. As the Managing Members of GCGMH LLC, the general partner of GCGMH, Messrs. Chenault, Cutler, Fialkow and Taneja shared voting and investment power with respect to shares held by GC Group VI LP. GCGM Investment Holdings, L.P. is a limited partner of GC Group VI LP with a pecuniary interest in the reported securities. GC Partners Holdings, L.P. is a limited partner of GCGM Investment Holdings, L.P. with a pecuniary interest in the reported securities.

Issuer

Livongo Health, Inc.

CIK 0001639225

Entity typeother

Related Parties

1
  • filerCIK 0001180524

Filing Metadata

Form type
4
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 5:00 PM ET
Size
19.6 KB